Beta-adrenergic blockers and nitrovasodilators for the treatment of portal hypertension: the good, the bad, the ugly

Gastroenterology. 1997 Nov;113(5):1794-7. doi: 10.1053/gast.1997.v113.agast971131794.
No abstract available

Publication types

  • Clinical Trial
  • Editorial
  • Randomized Controlled Trial
  • Comment

MeSH terms

  • Adrenergic beta-Antagonists / therapeutic use*
  • Humans
  • Hypertension, Portal / drug therapy*
  • Isosorbide Dinitrate / adverse effects
  • Isosorbide Dinitrate / analogs & derivatives*
  • Isosorbide Dinitrate / therapeutic use
  • Propranolol / adverse effects
  • Propranolol / therapeutic use*
  • Vasodilator Agents / therapeutic use*

Substances

  • Adrenergic beta-Antagonists
  • Vasodilator Agents
  • Propranolol
  • Isosorbide Dinitrate
  • isosorbide-5-mononitrate